0.75 mL of solution, and the rest depends on your dose. A 2.5 mg vial reconstituted to 3.33 mg/mL occupies 2.5 ÷ 3.33 = 0.75 mL. At a 1 mg weekly dose that is 2 weeks; at 2.4 mg weekly it is 1 weeks — and both of those assume the vial contains its label claim, which is the assumption a content assay exists to test. Subtract one draw's dead space per dose: a few microlitres on a fixed-needle syringe, up to a hundred on a luer one.
On the detail: the single most useful thing to do is write the arithmetic on the vial label, because you will reconstruct it from memory at an inconvenient moment if you do not.
Rotation of injection site is a tolerability measure, not a pharmacokinetic one, but if you are going to do it you might as well do it right.
On filtration: a 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide onto the membrane — with a low-binding PVDF or PES membrane the loss is typically a few per cent.
Published data on syringe dead space quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more for conventional detachable-needle syringes.
One qualification: if your arithmetic and someone else's disagree by a factor of ten, one of you has made a unit error, and writing out the units at every step is the diagnostic.
If in doubt, use more diluent and accept the shorter usable window.